Correlation Between WPP PLC and Aquestive Therapeutics
Can any of the company-specific risk be diversified away by investing in both WPP PLC and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining WPP PLC and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between WPP PLC ADR and Aquestive Therapeutics, you can compare the effects of market volatilities on WPP PLC and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in WPP PLC with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of WPP PLC and Aquestive Therapeutics.
Diversification Opportunities for WPP PLC and Aquestive Therapeutics
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between WPP and Aquestive is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding WPP PLC ADR and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and WPP PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on WPP PLC ADR are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of WPP PLC i.e., WPP PLC and Aquestive Therapeutics go up and down completely randomly.
Pair Corralation between WPP PLC and Aquestive Therapeutics
Considering the 90-day investment horizon WPP PLC ADR is expected to under-perform the Aquestive Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, WPP PLC ADR is 1.74 times less risky than Aquestive Therapeutics. The stock trades about -0.18 of its potential returns per unit of risk. The Aquestive Therapeutics is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest 352.00 in Aquestive Therapeutics on December 28, 2024 and sell it today you would lose (50.00) from holding Aquestive Therapeutics or give up 14.2% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
WPP PLC ADR vs. Aquestive Therapeutics
Performance |
Timeline |
WPP PLC ADR |
Aquestive Therapeutics |
WPP PLC and Aquestive Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with WPP PLC and Aquestive Therapeutics
The main advantage of trading using opposite WPP PLC and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if WPP PLC position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.The idea behind WPP PLC ADR and Aquestive Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |